Managing IP held the second annual MIP Life Sciences Forum 2017 in New York on September 13. Over the past year IP owners in the life sciences sector faced unique opportunities and challenges when protecting their patents. Rapid developments in the landscape of drug discovery, research and pending proposals for reform in Congress meant that strategies to protect your IP needed rethinking. The Forum gave delegates the opportunity to:
SPEAKING QUERIES Natalie Canter Natalie.email@example.com +44 (0) 207 779 8730 SPONSORSHIP QUERIES: Melanie Petch firstname.lastname@example.org +44 (0) 207 779 8836 REGISTRATION & MARKETING QUERIES Gurveer Vasir email@example.com +44 (0) 207 779 8579
Stay of injunction in public interest: Edwards Lifesciences v Boston Scientific https://t.co/0TclM1zJaU
RT @titorendas: CJEU judgment in Louboutin red sole case to be delivered on June 12. Will the Court follow AG Szpunar's Opinion (available…
RT @ChrisCarani: Apple awarded $533m for design infrgment and $5m for utility infrgment. 2 certainties: appeal and more attention to design…
Technology alters the anti-counterfeiting landscape
Ellie Mertens reveals evolving technologies are changing the counterfeiting game on both sides, as a tool for both prevention and evasion
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2018 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International